originally posted on Jan. 7 2009
The two companies I'm interested in here are BioTime Inc.(BTIM) and Advanced Cell Technology Inc.(ACTC). Advanced Cell Technology recently licensed patents to BioTime Inc. for amongst other things, the commercialization of stem cell medicine. Currently the Bush Administration had passed a bill which eliminated the Congressional funding for stem cell research.
The entire Stem Cell Community is awaiting President Obama's decision on whether or not to allow government funding for their research. If Obama does decided to allow the funding I believe that These companies could be looking at a jump in value, however that is not my main concern.
Looking into the future, Regenerative Medicine could bring forth an entirely new type of medicine. It could be the solution to so many of the problems we currently face. Which in turn could create a multi-billion dollar marketplace, leaving BioTime Inc. as the patent holder for the commercialization of this intellectual property.
The patents are for a specific type of Stem Cell work. The great thing about it is that real embryonic cells are not required. Unlike some of the controversial work done by other companies which require stem cells from an actual human embryo, ACTC and BTIM have developed a way to transform an average skin cell into an embryonic state stem cell. This relieves all of the controversy associated with the research.
I believe that if this market is going to turn into something, these companies will be at the base of it all.
Remember to never invest any money that you can not afford to lose.
